Page 2 of Aurobindo Pharma

Aurobindo Pharma gains 3 per cent in early trade

On Thursday, it had touched a 52-week low of Rs 464.20 after one of its directors P Sarath Chandra Reddy…

Updated: November 11, 2022 12:01 IST

Aurobindo Pharma, CuraTeQ Biologics, Aurobindo manufacturing unit, Aurobindo Pharma, health news, pharma news,

Aurobindo Pharma’s CuraTeQ Biologics to invest around Rs. 300 crore for capacity expansion

Further, the board also approved entering into contract manufacturing operations (CMO) for biologicals for effective utilisation of capacities.

September 2, 2022 17:13 IST

Eli Lilly, Obesity, USFDA, Alzheimer's drug, Healthcare news, pharma news,

USFDA issues one observation to Aurobindo Pharma subsidiary’s plant

As per USFDA, Form 483 is issued to a firm’s management at the conclusion of an inspection when the investigator…

August 29, 2022 20:37 IST

USFDA approves Aurobindo Pharma-owned Eugia’s generic Vasopressin injection

Vasopressin Injection is indicated to increase blood pressure in adults with vasodilatory shocks, such as due to post-cardiotomy or sepsis,…

August 16, 2022 20:17 IST

Aurobindo Pharma, SEBI, USFDA inspections, healthcare news, pharma news,

Aurobindo Pharma’s Andhra Pradesh unit gets 3 USFDA observations after inspection

According to USFDA, Form 483 is issued to a firm’s management at the conclusion of an inspection when the investigator…

August 3, 2022 14:27 IST

The transaction comes into effect from April 1, 2022 and is expected to close by May 2022. (File)

Aurobindo Pharma acquires Veritaz domestic formation business for 171 crore

The transaction is for a consideration of Rs. 171 crore on debt-free cash-free basis. The transaction comes into effect from…

Updated: March 28, 2022 21:35 IST

Aurobindo Pharma rating – Buy: Eugia stake sale will unlock value

It would also establish value for residual biz; Buy retained despite near-term concerns

March 28, 2022 00:46 IST

Buy these two stocks for gains; Nifty nearing crucial overhead resistance around 17000-17200

The pullback rally continued in the market for second session and the Nifty is now entering a crucial overhead resistance…

December 23, 2021 08:26 IST

Nifty Pharma tanks 4.33%, records worst intra-day fall since December; Dr Reddy’s plummets 10%

Nifty Pharma index came under attack from bears on Tuesday forcing the sectoral gauge to close 4.33% lower, the worst…

July 27, 2021 16:40 IST

Nifty, Bank Nifty, Aurobindo Pharma, Wipro, Bandhan Bank

Charts suggest profit booking in Nifty, Bank Nifty may face hurdle in this range; Wipro, Aurobindo may rally

Soaring crude prices and strengthening USDINR may become hurdles in further progress for the Indian market.

July 3, 2021 10:59 IST

Aurobindo Pharma, HDFC Life, BPCL, Infosys

Stocks to buy: Nifty may rally if it crosses 15,800; BPCL, Infosys shares look strong on charts

The Nifty 50 index is heading for the levels of 16000/16200 in the next few weeks and the downside is…

June 9, 2021 08:52 IST

Nifty has to cross 15,350 to resume bullish trend; ICICI Bank, Tata Motors among 4 technical stocks to buy

On a daily chart the 50-day moving average was a major hurdle for the market and is positive for the…

March 24, 2021 09:14 IST

Pharma shares regaining momentum, resuming up-trend; here’s how to shape your stock portfolio

Based on technical analysis, ICICI Direct has carved out a list of stocks that makes a multi-cap pharma stock portfolio.

February 4, 2021 13:54 IST

3 pharma stocks set to gain 25% as cardiac remains dominant therapy in Indian pharma market

According to the brokerage firm, Lupin, Glenmark, JB Chemicals, and Cipla are likely to gain market share among listed players.

October 1, 2020 16:15 IST

Stocks in focus: Aurobindo Pharma, Lakshmi Vilas Bank, Spicejet, Hexaware, Future Enterprises, BSE

Developments around COVID-19 vaccine, trends in coronavirus cases, oil prices and other global cues will continue to sway market sentiment

September 16, 2020 08:50 IST

Stocks in focus: IRCTC, HDFC, Wipro, Ashoka Buildcon, IndusInd Bank, defence, aerospace stocks

Ashok Leyland, Tata Power, Aurobindo Pharma, Bharat Forge, Century Plyboards, Cummins India, Graphite India, GSFC, Gulf Oil Lubricants, Natco Pharma,…

August 12, 2020 09:05 IST

Pharma earnings to reflect full COVID-19 impact in Apr-Jun quarter; 4 pharma stocks to gain up to 16%

Pharmaceutical sector will reflect the full impact of COVID-19 restrictions on the back of pre-buying in chronic therapies in March…

July 7, 2020 15:38 IST

Sun Pharma, Aurobindo Pharma among top stock picks from Pharma sector; CLSA sees gain up to 30%

Among pharma stocks, the top stock picks of CLSA are Sun Pharma, Cipla, Aurobindo Pharma and Cadila Healthcare, recommending a…

May 8, 2020 14:14 IST

Related News

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

China exits Pakistan’s $60 billion CPEC flagship project; Islamabad turns to ADB for funding

China exits Pakistan’s $60 billion economic corridor project; Islamabad turns to ADB for funding

New Zealand visa application, visa police certificates, visa Regional Passport Office, Indian Ministry of External Affairs, Immigration New Zealand

New Zealand issues new rules for Indian national visa applicants

GST cut backfired? your health insurance premium may go up by up to 5 pc, says report

ICPC 2025: IITs struggle as colleges from Russia, Japan, and China dominate global coding contest

ICPC 2025: IITs struggle as Russia, Japan, and China dominate global coding contest

What does a $1 trillion salary mean – What can it buy and how rich does it make you?

Life1 hr ago

Elon Musk, CEO of Tesla, is expected to become the first trillionaire in the world due to a new pay grade adding 423.7 million shares worth $1 trillion to his paycheck. This would make him wealthier than entire nations and have a major impact on various sectors, global politics, and scientific research. He would also be 100 times richer than the Ambani family.

View all shorts